![]() | Up a level |
Bolandi, S.M. and Abdolmaleki, Z. and Assarehzadegan, M.-A. (2021) Bevacizumab regulates inflammatory cytokines and inhibits VEGFR2 signaling pathway in an ovalbumin-induced rat model of airway hypersensitivity. Inflammopharmacology, 29 (3). pp. 683-694.